GLP-1 Drugs Are Reshaping What Nutrition Science Needs to Answer Sunday's sessions addressed a clinical challenge that will define nutritional science for the next decade: how to manage the nutritional needs of millions of patients on GLP-1 receptor agonists drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) that suppress appetite so effectively they create real risk of protein and micronutrient deficiency, as covered in prior reporting on the ADA's 2026 scientific sessions
CareBareRX's published materials state delivery typically occurs within five to seven days of prescription issuance
Mounjaro KwikPen is a prefilled once-weekly injectable weight loss pen
As people who are losing weight need to purchase new clothes that fit their changing bodies, this could result in a temporary surge in revenue for clothing retailers, including plus-size specialists who often cater to a broad range of sizes
Binge-eating disorder is a complex, she said, and the most effective ways of dealing with it are relearning behaviors, regulating emotions, and identifying triggers which are done through therapy, not by taking pills
Hong JH, Kwon YS, Kim IY
